NEXGEL INC (NXGL) Fundamental Analysis & Valuation

NASDAQ:NXGL • US65344E1073

Current stock price

0.831 USD
-0.12 (-13.03%)
At close:
0.79 USD
-0.04 (-4.93%)
After Hours:

This NXGL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NXGL Profitability Analysis

1.1 Basic Checks

  • In the past year NXGL has reported negative net income.
  • NXGL had a negative operating cash flow in the past year.
  • In the past 5 years NXGL always reported negative net income.
  • In the past 5 years NXGL always reported negative operating cash flow.
NXGL Yearly Net Income VS EBIT VS OCF VS FCFNXGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -24.78%, NXGL is in line with its industry, outperforming 45.65% of the companies in the same industry.
  • NXGL has a Return On Equity (-55.53%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -24.78%
ROE -55.53%
ROIC N/A
ROA(3y)-35.81%
ROA(5y)-46.56%
ROE(3y)-62.13%
ROE(5y)-690.12%
ROIC(3y)N/A
ROIC(5y)N/A
NXGL Yearly ROA, ROE, ROICNXGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K

1.3 Margins

  • NXGL's Gross Margin of 38.30% is on the low side compared to the rest of the industry. NXGL is outperformed by 69.57% of its industry peers.
  • NXGL's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for NXGL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y266%
GM growth 5YN/A
NXGL Yearly Profit, Operating, Gross MarginsNXGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. NXGL Health Analysis

2.1 Basic Checks

  • NXGL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NXGL has been increased compared to 1 year ago.
  • NXGL has more shares outstanding than it did 5 years ago.
  • NXGL has a worse debt/assets ratio than last year.
NXGL Yearly Shares OutstandingNXGL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
NXGL Yearly Total Debt VS Total AssetsNXGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of -1.39, we must say that NXGL is in the distress zone and has some risk of bankruptcy.
  • NXGL has a worse Altman-Z score (-1.39) than 61.96% of its industry peers.
  • NXGL has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
  • NXGL has a Debt to Equity ratio (0.15) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z -1.39
ROIC/WACCN/A
WACC9.86%
NXGL Yearly LT Debt VS Equity VS FCFNXGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

  • NXGL has a Current Ratio of 1.69. This is a normal value and indicates that NXGL is financially healthy and should not expect problems in meeting its short term obligations.
  • NXGL's Current ratio of 1.69 is on the low side compared to the rest of the industry. NXGL is outperformed by 71.20% of its industry peers.
  • NXGL has a Quick Ratio of 1.08. This is a normal value and indicates that NXGL is financially healthy and should not expect problems in meeting its short term obligations.
  • NXGL has a Quick ratio of 1.08. This is in the lower half of the industry: NXGL underperforms 74.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.08
NXGL Yearly Current Assets VS Current LiabilitesNXGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. NXGL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.33% over the past year.
  • Looking at the last year, NXGL shows a very strong growth in Revenue. The Revenue has grown by 73.38%.
  • Measured over the past years, NXGL shows a very strong growth in Revenue. The Revenue has been growing by 64.56% on average per year.
EPS 1Y (TTM)38.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
Revenue 1Y (TTM)73.38%
Revenue growth 3Y77.64%
Revenue growth 5Y64.56%
Sales Q2Q%-0.2%

3.2 Future

  • NXGL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.14% yearly.
  • NXGL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 36.74% yearly.
EPS Next Y28.6%
EPS Next 2Y37.03%
EPS Next 3Y37%
EPS Next 5Y29.14%
Revenue Next Year37.34%
Revenue Next 2Y39.79%
Revenue Next 3Y41.88%
Revenue Next 5Y36.74%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NXGL Yearly Revenue VS EstimatesNXGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M
NXGL Yearly EPS VS EstimatesNXGL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. NXGL Valuation Analysis

4.1 Price/Earnings Ratio

  • NXGL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year NXGL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXGL Price Earnings VS Forward Price EarningsNXGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXGL Per share dataNXGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NXGL's earnings are expected to grow with 37.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.03%
EPS Next 3Y37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NXGL Dividend Analysis

5.1 Amount

  • NXGL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NXGL Fundamentals: All Metrics, Ratios and Statistics

NEXGEL INC

NASDAQ:NXGL (3/13/2026, 8:00:02 PM)

After market: 0.79 -0.04 (-4.93%)

0.831

-0.12 (-13.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11
Earnings (Next)03-30
Inst Owners7.27%
Inst Owner Change7.29%
Ins Owners8.24%
Ins Owner Change-2.11%
Market Cap6.76M
Revenue(TTM)11.66M
Net Income(TTM)-2.88M
Analysts82.86
Price Target6.12 (636.46%)
Short Float %0.03%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-12.04%
Min EPS beat(2)-26.05%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-5.04%
Min EPS beat(4)-26.05%
Max EPS beat(4)11.76%
EPS beat(8)4
Avg EPS beat(8)-11.18%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.65%
Min Revenue beat(2)-9.08%
Max Revenue beat(2)-8.21%
Revenue beat(4)1
Avg Revenue beat(4)-4.18%
Min Revenue beat(4)-9.08%
Max Revenue beat(4)0.94%
Revenue beat(8)4
Avg Revenue beat(8)-4.41%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF N/A
P/OCF N/A
P/B 1.3
P/tB 2.02
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS1.43
BVpS0.64
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.78%
ROE -55.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.3%
FCFM N/A
ROA(3y)-35.81%
ROA(5y)-46.56%
ROE(3y)-62.13%
ROE(5y)-690.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y266%
GM growth 5YN/A
F-Score6
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.75%
Cap/Sales 0.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.08
Altman-Z -1.39
F-Score6
WACC9.86%
ROIC/WACCN/A
Cap/Depr(3y)166.83%
Cap/Depr(5y)273.19%
Cap/Sales(3y)9%
Cap/Sales(5y)18.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
EPS Next Y28.6%
EPS Next 2Y37.03%
EPS Next 3Y37%
EPS Next 5Y29.14%
Revenue 1Y (TTM)73.38%
Revenue growth 3Y77.64%
Revenue growth 5Y64.56%
Sales Q2Q%-0.2%
Revenue Next Year37.34%
Revenue Next 2Y39.79%
Revenue Next 3Y41.88%
Revenue Next 5Y36.74%
EBIT growth 1Y24.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.13%
EBIT Next 3Y42.97%
EBIT Next 5Y32.41%
FCF growth 1Y35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.73%
OCF growth 3YN/A
OCF growth 5YN/A

NEXGEL INC / NXGL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NEXGEL INC (NXGL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NXGL.


What is the valuation status of NEXGEL INC (NXGL) stock?

ChartMill assigns a valuation rating of 1 / 10 to NEXGEL INC (NXGL). This can be considered as Overvalued.


How profitable is NEXGEL INC (NXGL) stock?

NEXGEL INC (NXGL) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for NXGL stock?

The Earnings per Share (EPS) of NEXGEL INC (NXGL) is expected to grow by 28.6% in the next year.